PRNP and prion disease: A preclinical alteration of CaN has been reported in the TgPG14 mouse model of inherited prion disease [25,26], and treatment of prion-infected mice with the CaN inhibitor FK506 delays disease onset and promotes PrP degradation [27,28,29].